##
|||Page|
|---|---|---|
|Reference and administrative|information||
|Report ofthe trustees|||
|Auditor's
report||5-7|
|Statement offinancial activities|||
|8alance sheet|||
|Notes to the accounts||10-14|
|Charity name|||THE RICHARD DIMBLEBYCANCER FUND|THE RICHARD DIMBLEBYCANCER FUND|THE RICHARD DIMBLEBYCANCER FUND|THE RICHARD DIMBLEBYCANCER FUND|THE RICHARD DIMBLEBYCANCER FUND|
|---|---|---|---|---|---|---|---|
|Registered
chadty|||247558|||||
|Address|||4th Floor, Management|||Offices||
||||Bermondsey||Wing|||
||||Guys Hospital|||||
||||Great Maze|Pond||||
||||London|||||
||||SE1 9RT|||||
|Trustees||||||||
|Jonathan||Dimbleby||||Chairman||
|Helen Boaden||||||Deputy Chair||
|Homish|Sinclair|||||Honorary|Treasurer|
|Frederick||Dimbleby||||||
|Liz Price||||||||
|Amia Purushotham||||||||
|Jo Railing||||||||
|Kyle Taylor||||||||
|Patricia|Brolly|||||||
|Paula Hargadon|||Cancer Care||Map Co-Director|||
|Robirt Prltchard|||Cancer Care||Map Co-Director|||
|Luis Jacobs|||Cancer Care||Map Content Manager|||
|Advisors:||||||||
|Auditor|||Edwards and||Keeping,|Chartered|Accountants|
||||Unity Chambers|||||
||||34 High East||Street|||
||||Dorchester|||||
||||Dorset DT1|1HA||||
|Investment||managers|Cazenove
Capital Management|||||
||||12Moorgate|||||
||||London EC2R 6DA|||||
||||NatWest
Bank|||||
||||PO Box 35|||||
||||10Southwsrk||Street|||
||||London, SE1||1TT|||
|Professional|||Filanthropia|Consulting||Limited||
|Governance||Advisor|Heath House|||||
||||Alldens
Lane|||||
||||Godalming,|Surrey GU8 4AP||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||Unrestricted|Restricted|Total funds|Total funds|
|---|---|---|---|---|---|---|---|
|||||funds|funds|2023|2022|
||||Notes|E|E|E|6|
|Income from:||||||||
|Donations||||64,199||64,199|35,003|
|Legaaes||||15,047||15,047||
|Grants - not performance||related||61,300||61,300||
|Charitable
activity grants||- NHS England||||||
|22/23|||||145,000|145,000|150,000|
|Charitable
activity grants||- NHS England||||||
|23/24|||||'I00,000|100,000||
|Fundrsising
events||||||||
|investment
Income||||||||
|Income fmm managed|funds|||1,429||1,429|125|
|Bank deposit interest||||'I,169||1,169|53|
|Total income||||143,144|245,000|388,144|239,981|
|Expenditure
on:||||||||
|Raising funds||||17,724||17,724|20,178|
|Charitable
Activities||||1,550|206,909|208,459|293,149|
|Total expenditure||||19,274|206,909|226,183|313,327|
|Net Income/(deficit)|before investment|||||||
|gains and losses||||123,870|38,091|161,961|(73,346)|
|Transfer between
funds||||(23,506)|23,506|||
|Net gains/(losses)
on|investments|||||||
|Net income/(deficit)|for|the year||100,364|61,597|161,961|(73,346)|
|Reconciliation
offunds||||||||
|Funds brought
forward||||136,903|(26,006)|110,897|184,243|
|Funds carried forward||||237,267|35,591|272,858|110,897|
##
##
||||Unrestricted|Restricted|Total funds|Total funds|
|---|---|---|---|---|---|---|
||||funds|funds|2022|2021|
||||8|8|8|8|
|Income from:|||||||
|Donations and legacies|||35,003||35,003|'I2,975|
|Grants
—not performance||related|46,800|6,000|54,800|45,525|
|Charitable
activity grants||- NHS England||150,000|150,000|150,000|
|Fundraising
events|||||||
|Investment
income:|||||||
|Income from managed|funds||125||125||
|Bank deposit interest|||53||53||
|Total income|||83,981|156,000|239,981|208,511|
|Expenditure
on:|||||||
|Raising funds|||20,178||20,178|20,177|
|Charitable
Ac8vities|||(3,526)|296,675|293,149|138,703|
|Total expenditure|||16,652|296,675|313,327|158,880|
|Net income/(deficit)|before investment||67,329|(140,675)|(73,346)|49,631|
|Net gains/(losses)
on|investments||||||
|Net incomel(deficit)|for|the year|67,329|(140,675)|(73,346)|49,631|
|Reconciliation offunds|||||||
|Funds brought
forward|||69,574|114,669|184,243|134,612|
|Funds carried forward|||136,903|(26,006)|110,897|184,243|
##
##
||||||Total funds|Total funds|
|---|---|---|---|---|---|---|
||||||2023|2022|
|||||Notes|5||
|Ffxed assets|||||||
|Tangible assets|||||1,270|2,033|
||||||1,270|2,033|
|Current assets|||||||
|Investments|||||47,000|47,000|
|Debtors|||||100,230|2,617|
|Cash at bank|and|fn hand|||137,441|100,775|
||||||284,671|150,392|
|Liabilities|||||||
|Creditors: amounts|||falling due within one year||(13,083)|(41,528)|
|Net current assets|||||271,588|108,864|
|Net assets|||||272,858|110,897|
|Funds|||||||
|Unrestricted|income||funds||||
|General income|||funds||237,267|136,903|
|Ressicted funds|||||35,591|(26,006)|
|Total funds|||||272,858|110.897|
##
##
##
##
##
##
##
|3 cost|s ofcharita|ble|activities|||||
|---|---|---|---|---|---|---|---|
|||||||2023f|2622
K|
|Online|information|and|support|||180,396|271,297|
|cancer|Information|and|support service cost (aimhhrhy|cnncer cnw annenrnh|Fund)||(6,350)|
|Support|and governance||casts|||28,063|28,202|
|||||||208,459|293,149|
|ritable
activiti|es is shown
in th|e table below:||||
|---|---|---|---|---|---|
||||Total|Fund|Charitable|
||||allocated|ItsIslng|Activities|
||||f|f|f|
|Otilce running|costs||3,880|388|3,492|
|Administration|and operations|salaries|29,719|11,888|17,831|
|Audit and accountancy|||4.426|442|3,984|
|Consultancy|fees||1,550||'I,550|
|Insurance|||1,339|133|1.206|
||||40,914|12,851|28,063|
|All costs were allocated on the basis|All costs were allocated on the basis|All costs were allocated on the basis|ofstaff time, based on activities
d|uring
the year.||
|---|---|---|---|---|---|
|6 Net Incame forthe year||||||
|This isslated|alter charging:|||2023f|2022
f|
|Depreciation||||763||
|Accountants'|fees|||||
|Audit fees||||1,980|1,800|
|Other services - accountancy||||2,446|2,837|
|6information|regarding|employees|snd trustees|||
|||||2023
f|2022f|
|Salanes||||108,014|101,223|
|National
Insurance||||6,207|6.182|
|Pension contributions||||1,532|1,487|
|||||115,753|108,892|
##
##
##
|7 Tangible|fixed assets|||||
|---|---|---|---|---|---|
|||||Fixtures, fittings||
|||||and|equipment|
|Cost||||||
|At 1 August|2022||||3,050|
|Additions||||||
|Disposals||||||
|At 31July|2023||||3,050|
|Depreciation||||||
|At 1 August|2022||||1,017|
|Eliminated|on disposals|||||
|Charge for|the year||||763|
|At 31July|2023||||'I,780|
|Net book value||||||
|At 31 July 2023|||||1,270|
|At 31 July 2022|||||2,033|
|8 Current|Asset Investments|||||
||||Cash|Total|Total|
||||Equivalents|2023|2822|
||||||E|
|Valuation||||||
|At 1 August|2022||47,000|47,000|47,000|
|Acquisitions|st coal|||||
|Disposal proceeds||||||
|Realised gains/(fosses)||on disposal||||
||||47,000|47,000|47,000|
|Unrealised|gains/(losses)|on revaluation||||
||||47,000|47,000|47,000|
|Cash deposits|||2,192|2,192|2,117|
|At 31 July|2023||49,192|49,192|49,117|
##
##
|9 Debtors|||||||||
|---|---|---|---|---|---|---|---|---|
||||||||2023|2022|
||||||||8|8|
|Other debtors|||||||100,230|2,617|
||||||||100,230|2,B17|
|All debtors are due|||within|one year.|||||
|10 Creditors:||amounts||faglng due within one year|||||
||||||||2023|2022|
||||||||8|8|
|Amount due to Dimbleby||||Cancer Research Fund||||33,358|
|Other creditors|||||||13,083|8,170|
||||||||13,083|41,528|
|11 Funds|||||||||
||||||General|Restricted|Restricted|Total|
||||||funds|fund other|fund NHSE|funda|
||||||8|8|8|0|
|At 1 August 2022|||||136,903|1,475|(27,481)|110,897|
|Incoine|||||143,144||245,000|388,144|
|Expenditure|||||(19,274)||(206,909)|(226, 'i 83)|
|Net investment||gains|||||||
|Transfers between|||funds||(23,506)||23,508||
|At 31 July 2D23|||||237,267|1,475|34,116|272 858|
|Represented|by:-||||||||
|Tangible fixed|assets||||1,270|||1,270|
|Net current assets|||||235,997|1,475|34,116|271,588|
||||||237,267|1,475|34,116|272,858|
||||||General|Restricted|Restricted|Total|
|Prior year|||||funds|fund other|fund NHSE|funds|
||||||2|0|0||
|At 1 August 2021|||||69.574|15,270|99,399|184,243|
|Income|||||83,981|6,000|150,000|239,981|
|Expenditure|||||(16,652)|(19,795)|(276,880)|(313,327)|
|Net investment||gains|||||||
|At 31 July 2022|||||136,903|1,475|(27,481)|110,897|
##